NCT03059914

Brief Summary

The purpose of this investigator-initiated study is to compare new bone formation through histomorphometric analysis following maxillary sinus augmentation using two different bone graft materials. A total of twenty, sinus augmentation via a lateral approach will be performed for subjects requiring sinus augmentation for implant placement and randomly divided into 2 groups. These subjects will receive one of two different bone graft materials: 1) Anorganic bovine bone matrix- InterOss (Group A), 2) Anorganic bovine bone matrix- Bio-oss (Group B). At the time of implant placement (eight months after the sinus augmentation procedure), two bone biopsies will be collected from augmented site for the histomorphometric analysis. The percentage of vital bone will be measured and analyzed statistically, also the following will be measured: percentage of non-vital bone, percentage of non-bone material , and the percentage of connective tissue.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

August 10, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2020

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

May 1, 2024

Completed
Last Updated

May 1, 2024

Status Verified

April 1, 2024

Enrollment Period

2.9 years

First QC Date

February 16, 2017

Results QC Date

January 31, 2023

Last Update Submit

April 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage of New Vital Bone.

    Vital bone as seen in histology from the collected bone cores.

    8 months post operative after the initial sinus augmentation surgery.

Secondary Outcomes (2)

  • Cumulative Percentage of Bone Marrow and Fibrous Tissue

    Eight months post-op sinus augmentation

  • Space

    8 months

Study Arms (2)

InterOss

EXPERIMENTAL

Maxillary sinus augmentation using ABBM Inteross ( Xenograft)

Device: InterOss

Bio-oss

ACTIVE COMPARATOR

Maxillary sinus augmentation using ABBM Bio-oss ( Xenograft)

Device: Bio-oss

Interventions

InterOssDEVICE

Anorganic bovine bone mineral - Xenograft

InterOss
Bio-ossDEVICE

Anorganic bovine bone mineral ( Xenograft)

Bio-oss

Eligibility Criteria

Age18 Years - 103 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old who are able to read and sign an informed consent form.
  • Patient who has good oral hygiene (Full-mouth plaque score \<25%).
  • Subject would be available for study monitoring and follow-up visits.
  • Patients with missing teeth in the maxillary posterior region who will require sinus augmentation for implant placement. The patients may be partially or completely edentulous.
  • Patient is a candidate for delayed implant placement approximately 8 months following sinus grafting

You may not qualify if:

  • Alcohol, drug dependency.
  • Signs or symptoms of chronic maxillary sinus disease.
  • Current smoker.
  • History of head and neck radiation treatment.
  • Poor health, conditions like uncontrolled diabetes, uncontrolled hypertension or other uncontrolled systemic disease.
  • Physical or psychological reason that might affect the surgical procedure or the subsequent prosthodontic treatment and/or required follow-up examinations.
  • Also, subjects who are nursing or pregnant will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda University school of dentistry

Loma Linda, California, 92350, United States

Location

MeSH Terms

Conditions

Anodontia

Condition Hierarchy (Ancestors)

Tooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Sarat Ummethala
Organization
Loma Linda University Health

Study Officials

  • Jaime Lozada

    Loma Linda University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Program Director Implant Dentistry

Study Record Dates

First Submitted

February 16, 2017

First Posted

February 23, 2017

Study Start

August 10, 2017

Primary Completion

June 26, 2020

Study Completion

June 26, 2020

Last Updated

May 1, 2024

Results First Posted

May 1, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations